Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Arvinas, Inc. (ARVN)
Price$9.39Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $262.6M | $263.4M | $78.5M | $131.4M | $46.7M | $21.8M | $18.3M | $14.3M | $7.6M |
| Research & development | $285.2M | $348.2M | $379.7M | $315.0M | $180.4M | $108.4M | $67.2M | $45.2M | $28.8M |
| Operating expenses | $381.1M | $513.6M | $480.0M | $394.6M | $242.0M | $146.7M | $94.5M | $58.1M | $32.3M |
| Operating income | −$118.5M | −$250.2M | −$401.5M | −$263.2M | −$188.4M | −$120.8M | −$51.5M | −$43.8M | −$24.8M |
| Operating margin | −45.13% | −94.99% | −511.46% | −200.30% | −403.43% | −554.13% | −281.42% | −306.31% | −326.70% |
| EBITDA | −$115.5M | −$245.6M | −$396.7M | −$256.9M | −$183.6M | −$117.6M | −$49.9M | −$43.1M | −$24.4M |
| EBITDA margin | −43.98% | −93.24% | −505.35% | −195.51% | −393.15% | −539.45% | −272.68% | −301.37% | −322.12% |
| Net income | −$80.8M | −$198.9M | −$367.3M | −$282.5M | −$191.0M | −$119.3M | −$70.3M | −$41.5M | −$24.0M |
| Net profit margin | −30.77% | −75.51% | −467.90% | −214.99% | −408.99% | −547.25% | −384.15% | −290.07% | −317.32% |
| Basic EPSper basic share | -$1.14 | -$2.77 | -$6.62 | -$5.31 | -$3.82 | -$3.02 | -$2.13 | -$25.45 | -$15.08 |
| Diluted EPSper diluted share | -$1.14 | -$2.77 | -$6.62 | -$5.31 | -$3.82 | -$3.02 | -$2.13 | -$25.45 | -$15.08 |
Owners
Reported shareholders
11.65%of listed shares
BlackRock, Inc.7.61M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 11.65%7.61M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 6.31%4.12M shares |
D. E. Shaw & Co., Inc. | 5.35%3.5M shares |
Pfizer Inc | 5.30%3.46M shares |
ARMISTICE CAPITAL, LLC | 4.28%2.8M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 4.16%2.71M shares |
TWO SIGMA INVESTMENTS, LP | 3.94%2.57M shares |
STATE STREET CORP | 3.36%2.2M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.55%1.67M shares |
Qube Research & Technologies Ltd | 2.44%1.59M shares |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2.16%1.41M shares |
FEDERATED HERMES, INC. | 2.08%1.36M shares |
Nextech Invest Ltd. | 1.72%1.12M shares |
Houston John G | ≈1.72%1.12M shares |
ACADIAN ASSET MANAGEMENT LLC | 1.30%848.38K shares |
Hillsdale Investment Management Inc. | 1.15%750.9K shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 1.12%728.15K shares |
TCG Crossover Management, LLC | 1.08%707.1K shares |
DIMENSIONAL FUND ADVISORS LP | 1.00%654.91K shares |
GOLDMAN SACHS GROUP INC | 0.98%640.81K shares |
Percentages use 65.3M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 24, 2026Form 4 · 10b5-1 | Saik AndrewChief Financial Officer | SellCommon Stock | 5.7K | $8.16 | $46.5K | 187.4K |
| Jun 17, 2026Form 4 · 10b5-1 | Cacace Angela MChief Scientific Officer | SellCommon Stock | 2.6K | $7.60 | $19.6K | 180.4K |
| May 21, 2026Form 4 | Teel RandyPresident and CEO | SellCommon Stock | 2.2K | $9.04 | $20.0K | 285.0K |
| May 11, 2026Form 4 | Saik AndrewChief Financial Officer | SellCommon Stock | 11.1K | $9.94 | $110.7K | 193.1K |
| May 11, 2026Form 4 | Loomis David KVP, Chief Accounting Officer | SellCommon Stock | 1.9K | $9.94 | $19.1K | 40.2K |